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Background: Cytomegalovirus establishes lifelong persistency in the host and leads to life threatening situations in
immunocompromised patients. FoxP3+ T regulatory cells (Tregs) critically control and suppress innate and adaptive
immune responses. However, their specific role during MCMV infection, especially pertaining to their interaction
with NK cells, remains incompletely defined.
Methods: To understand the contribution of Tregs on NK cell function during acute MCMV infection, we infected
Treg depleted and undepleted DEREG mice with WT MCMV and examined Treg and NK cell frequency, number,
activation and effector function in vivo.
Results: Our results reveal an increased frequency of activated Tregs within the CD4+ T cell population shortly after
MCMV infection. Specific depletion of Tregs in DEREG mice under homeostatic conditions leads to an increase in
NK cell number as well as to a higher activation status of these cells as compared with non-depleted controls.
Interestingly, upon infection this effect on NK cells is completely neutralized in terms of cell frequency, CD69
expression and functionality with respect to IFN-γ production. Furthermore, composition of the NK cell population
with regard to Ly49H expression remains unchanged. In contrast, absence of Tregs still boosts the general T cell
response upon infection to a level comparable to the enhanced activation seen in uninfected mice. CD4+ T cells
especially benefit from Treg depletion exhibiting a two-fold increase of CD69+ cells 40 h and IFN-γ+ cells 7 days
p.i. while, MCMV infection per se induces robust CD8+ T cell activation which is also further augmented in
Treg-depleted mice. Nevertheless, the viral burden in the liver and spleen remain unaltered upon Treg ablation
during the course of infection.
Conclusions: Thus, MCMV infection abolishes Treg suppressing effects on NK cells whereas T cells benefit from
their absence during acute infection. This study provides novel information in understanding the collaborative
interaction between NK cells and Tregs during a viral infection and provides further knowledge that could be
adopted in therapeutic setups to improve current treatment of organ transplant patients where modulation of
Tregs is envisioned as a strategy to overcome transplant rejection.
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Mouse cytomegalovirus (MCMV) belongs to the family
of β-herpes viruses and shares many attributes with
human cytomegalovirus (HCMV). This makes it an at-
tractive tool to study CMV associated immune responses
in an infection model to better characterize the CMV-
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article, unless otherwise stated.infection pose as a major health concern in transplant-
ation medicine leading to life threatening consequences in
immunocompromised patients. As a means of suppressing
transplant rejections in patients, one novel proposed strat-
egy has been to adoptively transfer ex vivo expanded
FoxP3+ T regulatory cells (Tregs) [1]. In order to better
understand their role in acute CMV infection, this study
sets out to elucidate their interaction with NK cells and
effector T cells using an MCMV mouse model. Natural
Tregs are major players in suppressing the immune sys-
tem and are therefore important for controlling thentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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transcription factor FoxP3 is a specific regulatory gene
that distinguishes Tregs from other cell types and is
important for their suppressive function [4]. A frame-
shift mutation in the FoxP3 gene locus on the X-chro-
mosome in Scurfy mice results in a lethal multi-organ
inflammation caused by a massive proliferation of effector
T cells [5]. Despite the fact that Tregs are crucial for main-
tenance of the immune homeostasis, they are also known
to suppress the immune system in several diseased con-
ditions like cancer [6] or in the context of infections
for example induced by viruses [7-13]. In doing so, they
dampen pathogen-specific innate or adaptive immune
responses and impede pathogen clearance from the host
in most infectious settings. Treg suppression spans a
diverse cohort of immune cells including monocytes, den-
dritic cells (DCs), NK cells, NKT cells, CD4+ and CD8+
effector T cells [14,15]. They conduct their suppression
using an arsenal of mechanisms such as modulating the
bioavailability of IL-2 [16,17], production of certain cyto-
kines like IL-10, IL-35, TGF-β and signaling molecules like
cAMP [18], direct killing [19] or downregulating co-
stimulatory molecules CD80/86 on DCs via CTLA-4 by
trans-endocytosis [20] and thereby indirectly suppress T
effector responses. During acute MCMV infection, NK
cells predominantly confer resistance against MCMV-
induced pathogenesis by recognizing the viral m157 glyco-
protein on infected cells via the Ly49H receptor [21-23].
Thus, mouse strains exhibiting NK cells equipped with
this receptor like C57BL/6 are far more resistant than
strains lacking it like BALB/c. According to Dokun et al
[24,25], the NK response to MCMV constitutes three
phases. The first phase consists of an unspecific prolifera-
tion of NK cells with no preferential expansion of the
Ly49H+-MCMV specific subset, which is postulated to
be mostly cytokine dependent, followed by an MCMV-
specific expansion and subsequent outgrowth of Ly49H+
cells within the NK cell population. In contrast to other
Ly49 receptors, Ly49H associates with immunoreceptor
tyrosine-based activation motifs (ITAMs) on the adaptor
molecules DAP10 and DAP12, which are responsible for
inducing proliferation and activation [22,26]. The final
phase consists of a slow contraction of the total NK
cell response and frequency until baseline levels are
achieved [24,27].
Studies carried out by Ghiringhelli et al., demonstrated
that mutant Scurfy mice lacking the functional gene
FoxP3 exhibited, in addition to highly activated T effector
cells, a 10 fold greater NK cell proliferation [28]. Further-
more, enhanced cytotoxicity of NK cells was observed as
compared with WT mice with no added influence on their
activation state. In vitro studies as well as tumor mouse
models provided evidence that a direct control of Tregs
on NK cells may exist and results in impaired functionalityof NK cells in the presence of Tregs [28-30]. Membrane-
bound Transforming growth factor beta was proposed to
be involved in this process, since blocking antibodies of
this complex abolished the observed effects [28]. Recent
studies by Gasteiger et al. showed an indirect interaction
mediated by increased IL-2 levels produced by CD4+ T
cells upon Treg depletion [31,32]. IL-2 signaling on NK
cells induced proliferation and additionally enhanced their
cytotoxic function via increased sensitivity for target cells.
These observations led us to ask the question whether
this interaction between NK cells and Tregs is also of
importance in a viral model like MCMV, where NK
cell proliferation is initially cytokine dependent and
later driven by signaling of the NK cell-activating receptor
Ly49H.
Here, we show that boosting effects of Treg depletion
on NK cells under homeostatic conditions are overruled
upon MCMV infection with no preferential effects on
Ly49H subsets. The viral clearance remains unchanged
even though we observe enhanced general T cell acti-
vation, highlighting the outstanding role of NK cells in
controlling MCMV infection in C57BL/6 mice. These
results clearly indicate that the role of Treg-mediated
suppression on NK cells activated by MCMV infection is
at best negligible, whereas the activation of T cells is
further enhanced in the absence of Tregs.
Results
MCMV infection leads to elevated FoxP3+ Tregs in the
CD4+ T cell compartment
Cytomegalovirus has developed a number of immune-
evasion mechanisms to prolong its survival within the
host [33,34]. As Tregs display certain features to be a
possible target of immune evasion mechanisms, we set
out to characterize in detail the effect of MCMV on
Treg properties during the course of acute infection. We
first examined the Treg response initiated by MCMV
infection in the spleen as a site for primary MCMV repli-
cation. We observed a significant increase in the frequency
of these cells among CD4+ T cells from 40 hours post
infection (h p.i.) (Figure 1B) with a similar increase in the
absolute number of Tregs (Additional file 1: Figure S1).
This increase in Tregs persisted even at day 3 p.i. when
compared with mock-infected mice (Figure 1E) and is irre-
spective of DT treatment (Additional file 1: Figure S1D).
Furthermore, a larger proportion of infection-induced
Tregs showed a higher activation state indicated by in-
creased early activation marker CD69 expression after
40 h (Figure 1C) and 3 days p.i. (Figure 1F). This increase
was evident even by the mean fluorescence intensity
(MFI) of CD25 40 h p.i. (Figure 1D) and on day 3 p.i.
(Figure 1G). On day 7 p.i., representing the peak phase
of the T cell response to MCMV with regard to non-
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Figure 1 MCMV infection elevates Treg proportion in CD4+ T cell compartment early upon infection and DT administration results in
efficient depletion of Tregs in DEREG mice. (A) Infection and depletion scheme of experimental procedure. (B) FoxP3+ cells among splenic
CD4+CD3+ cells 40 h p.i. (C) the proportion of CD69+ cells among them and (D) their mean fluorescence intensity (MFI) of CD25 expression.
(E) shows the percentage of FoxP3+ cells in the CD4+ T cell compartment on day 3 p.i., (F) indicates the CD69+ cells within this subset and
(G) the MFI of CD25 expression. (H) The frequency of FoxP3+ cells among CD4+ T cells on day 7 p.i. (I) shows the CD25 expression on FoxP3+
cells and (J) the MFI of CTLA-4 expression on FoxP3+ cells on day 7 p.i. Data shown are from one representative experiment out of three in case
of frequency analysis (B), (E) and (H) and out of at least two with regard to activation markers (C), (D), (F), (G), (I) and (J) using 3-5 mice per
group. Significance of differences between means of groups was calculated by two tailed, unpaired Student’s t-test. (**) p < 0,01, (***) p < 0,001,
(ns) not significantly different.
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lation (Figure 1H) but still showed an increased MFI
of CD25 (Figure 1I) and of CTLA-4 (Figure 1J). Hence,
we hypothesized that depletion of FoxP3+ cells may result
in an enhanced anti-viral immune response. To investigate
the influence of Tregs during the acute phase of the
infection, we used DEREG mice, allowing for selective
depletion of FoxP3+ Tregs by Diphtheria toxin (DT)
administration [5]. Our data demonstrates that DT
treatment on day 0 and day 1 p.i. (Figure 1A) results
in efficient depletion of Tregs in our infection model
at all time points of analysis (Figure 1B, E and H).
The efficiency of the depletion is depicted in Additional
file 2: Figure S2B and is also represented in the total num-
ber of Tregs (Additional file 1: Figure S1A, B and C). Eventhough Treg frequencies reached WT levels by day 7 after
the first DT injection under homeostatic conditions, they
remained significantly lower in infected Treg-depleted
mice (Figure 1H and Additional file 2: Figure S2B). Hence,
we determined that DEREG mice serve as an efficient tool
for investigating acute MCMV disease progression in the
absence of Tregs.
Depletion of Tregs enhances NK cell frequency, number
and activation state under homeostatic conditions with
no added influence upon MCMV infection
NK cells are important cellular mediators of the immune
response needed to control MCMV infection. Previous
studies have demonstrated that Scurfy mice bear func-
tionally impaired Tregs [37] and therefore show higher
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the relationship between Tregs and NK cells, we investi-
gated the effect of Treg depletion on NK cells during
acute MCMV infection. We found that under homeo-
static conditions, DEREG mice that were depleted of
Tregs showed significantly higher frequencies of NK
cells with comparable NK cell number after 40 h p.i.
(Figure 2A and B) but this effect of depletion on NK
cells was even more pronounced at day 3 p.i. (Figure 2D)
and was reflected in the frequency and the total number
of NK cells per spleen at this time point (Figure 2E).
The increase in NK cells correlated with Treg depletion
as on day 7 p.i., when Tregs reached wild type levels in
mock infected mice, no differences in NK cell frequency
and number were detectable between the two groups
(Figure 2H). Surprisingly, the NK cell boosting effect of
Treg depletion is completely abolished upon MCMV
infection. No increase in NK cell frequency was observed
in infected mice (Figure 2A and D), while activation state
assessed by CD69 expression (Figure 2C and F) or matur-
ation determined by KLRG-1 expression (Figure 2G and I)
did not differ in the whole NK cell population as well
as in the Ly49H+ NK cell compartment (Figure 2I and
Additional file 3: Figure S3A, B). Furthermore, infection
failed to alter the frequency and number of Ly49H+ NK
cells even at a late time-point of day 7 p.i.. Although we
detected a notable increase in CD69 expression upon DT
treatment of DEREG mice, under homeostatic condi-
tions after 40 h, 3 days and 7 days p.i. (Figure 2C, F and
Additional file 3: Figure S3B), analysis of the maturation
state of Ly49H+ versus Ly49H− NK cells revealed an un-
altered composition of MCMV-specific versus unspecific
NK cells in uninfected as well as infected mice (Figure 2G
and I) although infection increased KLRG1 expression
irrespective of Treg depletion compared to uninfected
mice (Infected ≥ 60% of NK cells versus uninfected ≤40%
of NK cells) (Figure 2I). These findings suggest that Treg
depletion fails to favor an outgrowth of either of the two
NK cell subsets neither is the maturation altered. Hence,
simultaneous ablation of Tregs and MCMV infection does
not enhance the number or alter the phenotype of NK
cells in contrast to steady state depletion.
Interferon-γ production of NK cells in response to MCMV
is not further enhanced in the absence of Tregs
During the acute phase of MCMV infection Interferon-γ
(IFN-γ) proves indispensable for effective MCMV con-
trol with NK cells being the main producers early after
infection. Aside from granzymes and perforin, IFN-γ
production constitutes one of the most important coun-
teractive measures by NK cells against viral propagation
[38-41]. Therefore, to test for functional consequences
of Treg depletion on NK cells, we performed intracellular
FACS staining of IFN-γ after a 4-hour restimulation withIL-2 in the presence of Brefeldin A. Using this protocol,
modified from Mitrovic et al. [42], we could demonstrate
that about 25% of NK cells from infected animals ex-
pressed IFN-γ (Figure 3A and B) as compared with mock-
infected WT DT-treated animals after 40 h p.i. which
showed a minor unspecific proportion of IFN-γ+ NK cells
accounting for ≈ 2% of NK cells. However, quantification
of the frequency of the IFN-γ+ NK cells revealed no differ-
ences between DEREG MCMV + DT-treated and WT
MCMV + DT-treated mice, neither at the peak phase of
IFN-γ production of NK cells, at 40 h p.i., nor at day 3 p.i.
(Figure 3B and C). Fogel et al. reported a correlation be-
tween CD69 expression and IFN-γ production of NK cells
[43]. Interestingly, although we observed a minor increase
in CD69 expression on NK cells at these time points upon
Treg depletion under naïve conditions, the increase in
activation did not reflect the ability to produce IFN-γ
as DEREG DT-treated mice showed comparably low
frequencies of IFN-γ+ NK cells as WT DT-treated mice.
Analysis of the Ly49H sub-compartments again showed
no preferential effect of Treg depletion on either popula-
tion (Figure 3A and data not shown). To rule out any bias-
ing effects of IL-2 ex vivo restimulation, we performed
additionally a PMA/Ionomycin restimulation assay on NK
cells which revealed the same results but showed higher
activation in general (Additional file 3: Figure S3C).
Viral burden remains unaltered upon ablation of Tregs
In order to examine the contribution of Treg depletion
to viral clearance, we measured the viral load in the
infected-depleted mice versus infected-non-depleted ones
at different days p.i. Our results showed equally high viral
loads in spleen and liver from both experimental mouse
groups over the course of infection (Figure 4A and B). On
day 7 p.i., viral burden was close to the detection limit in
these organs and not detectable in the salivary glands
(data not shown) of DEREG MCMV + DT-treated mice as
well as WT MCMV + DT-treated ones, with no added
differences upon Treg depletion. Overall, we show that
viral clearance in immunocompetent DEREG mice, on
C57BL/6 genetic background, is independent of Treg
mediated function.
Ablation of Tregs results in a boosted general T cell
response
The unaltered viral load in spleen and liver raised ques-
tions about the influence of Treg depletion on the adap-
tive T cell response upon MCMV infection and its impact
on viral clearance. DEREG MCMV + DT-treated mice
showed an early and significant increase in activated T
cells assessed by CD69 expression in both the CD8+ as
well as more pronounced, in the CD4+ compartment after
40 h p.i. as compared with WT MCMV + DT-treated

































































































































































































































































































































































































































Figure 2 The Treg depletion associated boosting effect on NK cells under homeostatic conditions is neutralized upon MCMV infection.
(A) Frequency of NK cells and (B) number of NK cells gated on NK1.1+CD3− cells among live splenocytes and (C) their expression of CD69 as MFI
40 h p.i. (D) Proportion and (E) absolute number of splenic NK cells 3 days p.i. (F) MFI of activation marker CD69 and (G) maturation marker
KLRG-1+ cells, stratified according to Ly49H expression, on day 3 p.i. (H) NK cells among live cells on day 7 p.i and (I) their expression of KLRG-1
again stratified according to Ly49H expression. Data shown are from one representative experiment out of three in case of day 3 p.i. analysis
(D), (E), (F) and (G) and out of at least two with regard to 40 h and 7 days p.i. (A), (B), (C), (H) and (I) using 3-5 mice per group. Significance of
differences between means of groups was calculated by two tailed, unpaired Student’s t-test. (*) p < 0,05, (**) p < 0,01, (***) p < 0,001, (ns) not
significantly different.
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to non-inflationary T cell epitopes upon MCMV infection,
we examined the influence of Treg depletion at this time
point and observed that general T cell responses are in-
deed enhanced. Overall, the frequency of T cells among
splenic cells is increased with a simultaneous and sig-
nificant increase in the ratio of CD8+ to CD4+ T cells ininfected, Treg-depleted mice (Figure 5C). Furthermore up
to 90% of CD8+ T cells and 70% of CD4+ T cells expressed
low mean fluorescence intensity for CD62L as compared
with 65% and 45% respectively in WT MCMV infected
animals (Figure 5D and E). Strikingly, MCMV infection
induced KLRG-1 expression in half of all CD8+ T cells,
while infection plus Treg depletion further enhanced the
Figure 3 IFN-γ expression of NK cells upon infection remains unchanged after Treg depletion. (A) Representative FACS plots showing the
IFN-γ expression of live NK1.1+CD3− cells after IL-2 ex vivo stimulation and surface expression of Ly49H. (B) and (C) quantification of IFN-γ+ NK cells
40 h and 3 days p.i. Data are representative of two (B) or three (C) individual experiments with 3-5 mice per group. Significance of differences between
means of groups was calculated by two tailed, unpaired Student’s t-test. (***) p < 0,001, (ns) not significantly different.
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KLRG-1+ cells among CD8+ T cells (Figure 5F). In con-
trast to the influence on NK cells, the absence of Tregs
also leads to higher frequencies of T cells responding with
enhanced IFN-γ production in response to ex vivo restim-
ulation (Figure 5G and H). Furthermore, the frequency of
IFN-γ+CD4+ T cells increased two-fold in DEREG mice
that were infected and DT treated. Overall, we show that
Treg depletion and infection strongly promotes the ex-
pansion, activation and maturation of effector CD4+ and
CD8+ T cells with simultaneous increases in IFN-γ pro-
duction by both subsets.
Discussion
CMV is a medically important DNA virus with high
pathogenesis in immunocompromised and newborn
individuals, representing a major reason for organ rejec-
tion in transplanted patients. Although anti-viral therapies
to treat CMV disease are employed in the clinics, treat-
ment is associated with poor oral bioavailability, develop-
ment of anti-viral drug resistance over time and anti-viral
drug related cytotoxicities [44]. Hence, there remains an




































Figure 4 Treg depletion has no effect on viral clearance in spleen and
inoculation of sub-confluent mouse embryonic fibroblast (MEF) layers with
p.i. (B) Viral burden of the liver at the indicated time points. Data depicted
experiments with 3-5 mice per group. Limit of detection was determined bdifferent mechanism of action to reduce morbidity and
contain infection. Thus, targeting Tregs has been sugges-
ted as a potential cell mediated approach for immunother-
apy against infections [2].
A number of studies examining this concept, demon-
strated the contribution of Tregs in promoting suppres-
sion of pathogen specific effector responses [7-10,45-48],
while others showed beneficial effects of Tregs upon
infections [12,49-52]. In this study, we set out to primar-
ily examine the role of Tregs in modulating the MCMV-
specific NK cell responses during the acute phase of
infection, which until now remained incompletely defined.
We observed elevated Treg frequencies among CD4+ T
cells in the spleen early upon infection, indicating that
MCMV infection may preferentially support differenti-
ation of naïve T cells into Tregs, similarly described in a
hepatitis virus infection model [53] where TGF-β in-
duced by infection controlled this phenotypic change.
To specifically address the question of whether the in-
crease in Tregs influences the ongoing activation of innate
and adaptive immune responses, we utilized DEREG mice
to facilitate specific Treg depletion by Diphtheria toxin
(DT) administration [5]. The advantage of the rapid andViral burden liver
limit of detection
3 71,5
Dereg MCMV + DT
WT MCMV + DT
day post infection
liver of C57BL/6 DEREG mice. (A) Plaques developed after
spleen homogenates of infected mice obtained 40 h, 3 days and 7 days
shows geometric mean with 95% confidence interval of three pooled
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Figure 5 Absence of Tregs enhances adaptive immune response of CD4+ and CD8+ T cells. (A) Proportion of CD69+ among CD8+ and (B)
CD4+ T cells 40 h p.i. (C) Percentage of CD3+ cells among live splenocytes on day 7 p.i. stratified by CD8 and CD4 expression. (D) CD62Llow cells
within the CD8+ and (E) CD4+ T cell compartment as well as (F) KLRG-1 expression of CD8+ T cells 7 days p.i. (G) Quantification of IFN-γ+ cells
among CD8+ T cells and (H) CD4+ T cells upon ex vivo stimulation with PMA / Ionomycin obtained from spleens of mice infected for 7 days.
Data shown are from one representative experiment out of three for (A), (B), (C), (D), (E) and out of two (F), (G) and (H) using 3-5 mice per
group. Significance of differences between means of groups was calculated by two tailed, unpaired Student’s t-test. (*) p < 0,05 (**) p < 0,01, (***)
p < 0,001, (ns) not significantly different.
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opportunity to infect mice on the day of first DT injection
to really assess the influence of Tregs on NK cells during
virus replication and thus minimize effects occurring prior
to the onset of infection. This fact could account for the
contrasting results Sungur et al. reported in terms of
enhanced viral clearance upon CD25 antibody-mediated
Treg depletion starting 2 days before infection [54]. In
respect to these findings, we observed that under homeo-
static conditions, depletion of Tregs significantly increasedNK cell numbers and NK cell CD69 expression. Thus,
depletion prior to infection could contribute to this dis-
crepancy between both studies by conferring enhanced
anti-viral defense already before infection. As Tregs return
to baseline levels by day 7 p.i. in uninfected mice, our ex-
perimental mouse model avoids the development of artifi-
cial autoimmunity [55] and hence provides an unbiased
approach to examine the phenotypes observed here upon
infection. To further elucidate the interaction of Tregs
with NK cells, and its influence on control of MCMV
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bers and activation in the absence of Tregs. We detected
elevated NK cell frequencies in uninfected DEREG mice
depleted of Tregs consistent with findings reported in
Scurfy mice and FoxP3 DTR knock-in mice [28,32]. These
cells additionally showed notably higher CD69 expression.
In contrast, upon infection, we observed comparable NK
cell responses between Treg-depleted and non-depleted
mice. Studies by Fulton et al. and Lee et al. reported con-
cordantly increased NK cell numbers in the lungs of
Respiratory Syncytial Virus infected-BALB/c mice upon
Treg depletion, which was carried out again by CD25 anti-
body administration starting already 3 days prior to infec-
tion [56,57]. Using uninfected FoxP3 DTR knock-in mice,
Gasteiger et al. pointed out that the increase of NK cell
numbers upon Treg depletion corresponds to elevated
CD127+ NK cell frequencies, expressing higher amounts
of high affinity IL-2 receptor CD25 [31]. Therefore, en-
hanced IL-2 production by effector CD4+ T cells in the
absence of Tregs may represent the likely mechanism
underlying this phenomenon. This hypothesis was further
substantiated by experiments that showed abrogation of
this effect by blocking the IL-2 pathway or depleting the
CD4+ T cell compartment [32] and similarly reported by
Sitrin et al. in an autoimmune diabetes mouse model [58].
Our results in uninfected mice corroborate these findings
as we similarly detected higher activation of CD4+ T cells
upon Treg depletion. Although we observed a boosted
CD4+ as well as CD8+ T cell response in DEREG MCMV +
DT-treated mice as compared with WT MCMV + DT-
treated mice, we could not detect differences in NK
cell frequencies in infected mice suggesting that this
proposed mechanism will need further clarification under
a more infectious setting such as a salivary gland infection,
where the demand for Ly49H+ NK cells would be further
exemplified. A possible reason for this discrepancy could
be that NK cells already achieve maximal proliferation
upon tissue cultured MCMV infection and thus, fail to
benefit from Treg depletion or elevated IL-2 levels. Treg
depletion in MCMV-infected mice leads to higher pro-
liferation of effector T cells, predominantly CD8+ T cells
which represent the majority of T cells at day 7 p.i. Thus,
consumption of IL-2 by proliferating CD8+ T cells which
is not seen upon Treg depletion under homeostatic condi-
tions, may offer another potential explanation. Treg abla-
tion leads to similar frequencies of CD62low CD4+ T cells
as compared with those induced by MCMV infection
alone. However, CD8+ T cells are significantly more acti-
vated upon MCMV infection than upon Treg depletion of
naive mice and thus could abrogate IL-2 mediated effects.
The insensitivity of the viral clearance to a boosted T cell
response highlighted the importance of NK cells in limit-
ing WT MCMV replication in C57BL/6 mice emphasized
by a rapid clearance until day 7. The implications of Tregcontrol over effector CD8+ T cell response would prove
critical if the Ly49H receptor engagement was somehow
abrogated as observed in the case of mice challenged
with Δm157-strain of MCMV, where CD8+ effector T
cells critically governed the outcome of viral replication
in infected organs [42]. In Ly49H+ NK cell competent
C57BL/6 mice, we observed an initial viral burden that
was already 100-fold reduced and close to the detection
limit when the T cell response peaked. Our findings pro-
vide further support to the multi-functional importance
of NK cells spanning the innate and adaptive arms of
the immune system [59-61]. Furthermore, since MCMV
infection primarily induces stronger CD8+ T cell re-
sponses, the contribution of the enhanced CD4+ T cell
activation we observe upon infection in Treg depleted
mice would require further investigation. CD4+ T cells
are key players in establishing immunological memory
and moreover known to develop cytotoxic abilities to
directly attack infected cells under certain circumstances
[62-64]. This makes them an important factor during
MCMV infection and their importance may be further en-
hanced upon their suppression by Tregs. Thus, our results
provide new evidence that Tregs play a role in modulating
the immune response to MCMV infection, but this effect
seems to be restricted to the suppression of adaptive
immune cell activation. Our results suggest that Tregs en-
hance the general effector T cell response while NK cell
function remains unaltered. This expansion in the CD8 T
cell pool would warrant for further investigation into the
contribution of Treg depletion on the antigen-specific
effector T cell compartment after infection. The import-
ance of Treg regulation on CD8 T cells in the absence of
Ly49H-NK cell recognition has been recently analyzed in
an independent study described by us in collaboration
with Hansen and colleagues, showing enhanced activation,
cytotoxicity and improved viral clearance in DEREG Balb/
c mice depleted of Tregs [65]. Thereby, suggesting an im-
portant regulatory role by which NK-Ly49H function in
concert with Tregs modulate anti-MCMV T cell effector
responses [65]. This could be further extended into in-
fection models in C57BL/6 mice employing a Δm157
MCMV strain, where the requirement for antigen specific
T cells in viral clearance is further exemplified. Overall,
our findings provide a foundation for the development of
future Treg-mediated therapeutics in viral infections and




Previously described DEREG mice on C57BL/6 back-
ground were used, allowing for the efficient and selective
depletion of FoxP3+ T regulatory cells by the administra-
tion of Diphtheria toxin (DT) [5]. DT was administered
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infection and the following one. Male DEREG mice aged
8-12 weeks were used for experiments and gender- and
aged-matched WT littermates served as controls. Mice
were housed under specific pathogen free conditions at
the animal facility of Twincore (Hannover, Germany). The
protocol for this research study involving mice was ap-
proved by a suitably constituted Ethics Committee of the
institution and was performed in accordance with animal
welfare guidelines approved by institutional, state, and fed-
eral committees. Mice were sacrificed by CO2 asphyxi-
ation in accordance with German animal welfare law.
Every effort was made to minimize animal suffering.Virus
For infection, BAC derived MCMV WT Smith strain was
used [66], which was kindly provided by Martin Messerle
(Institute of Virology, Hannover Medical School, Germany).
Virus propagation was carried out on doxycycline induced
murine embryonic fibroblasts, also kindly provided by Dr.
Tobias May from the Helmholtz Center for Infection
Research and InSCREENeX (Braunschweig, Germany)
[67]. Mice were infected with 106 pfu of tissue cultured-
derived virus by the intraperitoneal route.Plaque assay
Viral titers were determined by plaque assay performed
on mouse embryonic fibroblasts (MEFs) as previously
described [68]. Spleens and livers were frozen with 0.5 ml
DMEM medium and after brief thawing homogenized
using a TissueLyserLT (Qiagen) (50 Hz, 2:30 min). Ten-fold
dilutions were prepared in duplicates and sub-confluent
MEF layers were inoculated with homogenates for 2 h at
37°C. Following incubation, the inoculum was removed and
cells were overlayed with 0.75% (w/v) carboxymethylcel-
lulose (Sigma) in growth medium for each well. Plaques
were counted after 6-8 days.Flow Cytometry
Red blood cells in single-cell suspensions of spleens were
lysed using RBC lysis buffer (150 mM NH4Cl, 10 mM
KHCO3, 0.1 mM EDTA). The isolated cells were counted
by Trypan Blue exclusion and adjusted to the same cell
number for FACS staining. After washing with PBS,
cells were stained with the LIVE/DEAD® Fixable Aqua
Dead Cell Stain Kit (Invitrogen, Life Technologies GmbH,
Darmstadt, Germany) to exclude dead cells. Following
incubation with FACS buffer (0.25% BSA/ 2 mM EDTA in
PBS) containing Fc-block (CD16/32, 2.4G2) for 10 min on
ice cells were stained for surface markers with the follow-
ing fluorochrome conjugated anti-mouse antibodies for
20 to 30 min on ice:CD3 (145-2C11), CD4 (GK1.5), CD8α (53-6.7), CD25
(PC61.5), CD62L (MEL-14), CD69 (H1.2 F3), KLRG-1
(2 F1), Ly49H (3D10), NK1.1 (PK136).
Cells were fixed by using the Foxp3/Transcription Fac-
tor Staining Buffer Set (eBioscience, affymetrix, Frankfurt,
Germany). Anti-mouse FoxP3 antibody FJK-16 s and anti-
mouse CTLA-4 antibody UC10-4B9 (BioLegend, London,
United Kingdom) were used for intracellular staining.
Unless otherwise stated, all antibodies were purchased
from eBioscience, affymetrix (Frankfurt, Germany). Sam-
ples acquisition was performed on an LSRII Flow cyt-
ometer (BD Bioscience GmbH, Heidelberg, Germany),
with the results analyzed using FlowJo software (Tree
Star, Inc. Ashland, USA). Accurate gating was confirmed
by single stains and fluorescence minus one controls,
with non-specific binding was estimated by isotype con-
trols. Cellular aggregates were excluded by SSC-W.
Ex vivo stimulation assays
NK cell production of Interferon- γ (IFN-γ) was assessed
by IL-2 re-stimulation in a 96-well U bottom plate. Sple-
nocytes in the amount of 3×106 were incubated with 250
U/ml IL-2 for 2 h initially, followed by an additional 2 h
in the presence of 3 μg/ml BrefeldinA with 125 U/ml.
For T cell ex vivo stimulation 25 ng/ml Phorbol-12-
myristate-13-acetate (PMA) and 250 ng/ml Ionomycin
were used for 4 h in the presence of 3 μg/ml BrefeldinA.
Cells were stained for surface markers as described
under Flow Cytometry. Intracellular staining for IFN-γ
was performed after fixation in 2% PFA in PBS for
20 min on ice and permeabilization in PBS containing
0.25% BSA, 2 mM EDTA, and 0.5% saponin. PE conjugated
anti-mouse IFN-γ antibody clone XMG1.2 (eBioscience,
affymetrix, Frankfurt, Germany) was used.
Statistics
Two-tailed, unpaired Student’s t-test was used to calcu-
late the statistical significance of differences between
means of groups or samples. A p-value <0.05 was con-
sidered significant, as indicated by asterisk signs: (*) for
P < 0.05, (**) for P < 0.01 and (***) for P < 0.001.
Additional files
Additional file 1: Figure S1. MCMV infection induces increase in Treg
frequency and number in infected Treg depleted mice. Total number of
FoxP3+CD4+ Tregs 40 h (A), 3 days (B) and 7 days p.i. (C) and DT treatment.
Infected wt mice showed increased Treg frequencies irrespective of
DT treatment (D). Data shown is representative of at least 2 experiments,
whereas data on day 3 p.i. is pooled from two individual experiments out
of three, significance was determined by two tailed, unpaired Student’s t
test. (*) p < 0,05.
Additional file 2: Figure S2. Selective depletion of Tregs in DEREG
mice. (A) Gating Strategy for examining Treg frequencies. (B) Representative
FACS plots showing the efficiency of Treg depletion in DEREG mice at 40 h,
day 3 and day 7 p.i. Also included is a representative FACS plot showing
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http://www.virologyj.com/content/11/1/145undepleted control mice. Data shown is representative of two experiments
with 2-4 mice per group.
Additional file 3: Figure S3. Activation and IFN-γ production by
NK-Ly49H+ cells in Treg depleted mice. (A) Shows activation with regard
to CD69 expression on Ly49H+NK1.1+ cells upon infection during Treg
depletion. Data shown is representative of at least two experiments with
3-4 mice per group. (B) Expression of early activation marker CD69 on NK
cells of infected mice is clearly reduced on day 7 in comparison to 40 h
and 3 days p.i. But the results support the observation that Treg depletion
under homeostatic conditions leads to higher NK cell activation. Data
shown is representative of two experiments with 2-4 mice per group.
(C) PMA/Ionomycin restimulation assay for splenic NK cell IFN-γ production
showed similar results as IL-2 restimulation but with higher unspecific
ex vivo activation. Groups consisted of 3-5 mice and significance was
determined by two tailed, unpaired Student’s t test. (***) p < 0,0001;
(ns) not significantly different.
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